Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase

Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase...

Descripción completa

Detalles Bibliográficos
Autores principales: Noseda, Roberta, Ripellino, Paolo, Ghidossi, Sara, Bertoli, Raffaela, Ceschi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473382/
https://www.ncbi.nlm.nih.gov/pubmed/34579259
http://dx.doi.org/10.3390/vaccines9091022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473382/
https://www.ncbi.nlm.nih.gov/pubmed/34579259
http://dx.doi.org/10.3390/vaccines9091022

Ejemplares similares